Perspective Therapeutics, Inc. CATX
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2002-05-31
Perspective Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,485,946 | $34.8M | 4.69% |
| MILLENNIUM MANAGEMENT LLC | 4,046,640 | $16.9M | 5.44% |
| CITADEL ADVISORS LLC | 3,640,204 | $15.2M | 4.9% |
| TWO SIGMA INVESTMENTS, LP | 1,003,474 | $4.2M | 1.35% |
| AQR CAPITAL MANAGEMENT LLC | 26,716 | $111,406 | 0.04% |
% of company = reported 13F shares ÷ shares outstanding. Based on the latest filings; not every holder reports every quarter.
Source: SEC EDGAR filings · CIK 0000728387 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.